These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3882006)

  • 41. Strategies for the drug treatment of depression.
    Cooper AJ; Magnus RV
    Can Med Assoc J; 1984 Feb; 130(4):383-90. PubMed ID: 6692235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tricyclic-induced seizures and absent ECT response.
    Byrne A; Silverstone P
    Br J Psychiatry; 1993 Nov; 163():691-2. PubMed ID: 8298846
    [No Abstract]   [Full Text] [Related]  

  • 43. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression.
    Janicak PG; Dowd S; Rado J; Welch MJ; Fogg L; O'Reardon J; Avery D; Coffey CE; Sampson S; Boutros N
    Am J Psychiatry; 2007 Jul; 164(7):1118; author reply 1118-9. PubMed ID: 17606665
    [No Abstract]   [Full Text] [Related]  

  • 45. [Indications for electroconvulsive therapy].
    Boiteux J; Roubaud L; Gandelet N; Nezelof S; Vittouris N; Bonin B; Sechter D; Bizouard P
    Encephale; 1997 Jun; 23 Spec No 3():21-6. PubMed ID: 9333557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [MAO inhibitors and depressive disorders today].
    Bonamy D; Olié JP; Lôo H
    Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly.
    Stoudemire A; Hill CD; Morris R; Martino-Saltzman D; Markwalter H; Lewison B
    Am J Psychiatry; 1991 Oct; 148(10):1336-40. PubMed ID: 1897613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A meta-analysis of electroconvulsive therapy efficacy in depression.
    Kho KH; van Vreeswijk MF; Simpson S; Zwinderman AH
    J ECT; 2003 Sep; 19(3):139-47. PubMed ID: 12972983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tricyclic antidepressants versus electroconvulsive therapy: a review of the evidence for efficacy in depression.
    Piper A
    Ann Clin Psychiatry; 1993 Mar; 5(1):13-23. PubMed ID: 8348195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Nottingham ECT Study. A double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness.
    Gregory S; Shawcross CR; Gill D
    Br J Psychiatry; 1985 May; 146():520-4. PubMed ID: 3893601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychotic vs. nonpsychotic depression: comparison of treatment response.
    Brown RP; Frances A; Kocsis JH; Mann JJ
    J Nerv Ment Dis; 1982 Oct; 170(10):635-7. PubMed ID: 6125562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does design determine results in ECT studies?
    Ives JO; Weaver L
    Am J Psychiatry; 1984 Mar; 141(3):468-9. PubMed ID: 6703120
    [No Abstract]   [Full Text] [Related]  

  • 55. Psychotic (delusional) depression: a meta-analysis of physical treatments.
    Parker G; Roy K; Hadzi-Pavlovic D; Pedic F
    J Affect Disord; 1992 Jan; 24(1):17-24. PubMed ID: 1347545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treating depressive disorders with continuation electroconvulsive therapy].
    Sartorius A; Henn FA
    Nervenarzt; 2005 Nov; 76(11):1363-9. PubMed ID: 16012868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression.
    Sackeim HA; Prudic J; Devanand DP; Decina P; Kerr B; Malitz S
    J Clin Psychopharmacol; 1990 Apr; 10(2):96-104. PubMed ID: 2341598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The sham ECT literature: implications for consent to ECT.
    Ross CA
    Ethical Hum Psychol Psychiatry; 2006; 8(1):17-28. PubMed ID: 16856307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular complications of ECT in depressed patients with cardiac disease.
    Zielinski RJ; Roose SP; Devanand DP; Woodring S; Sackeim HA
    Am J Psychiatry; 1993 Jun; 150(6):904-9. PubMed ID: 8494067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tricyclic-induced seizures and absent ECT response.
    Curran S
    Br J Psychiatry; 1994 Mar; 164(3):421. PubMed ID: 8199804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.